Kuros Biosciences AG (0RHR.L)
CHF 20.55
(1.23%)
CHF 20.55
(1.23%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 75.9 Million CHF | -8.49% |
| 2022 | 82.94 Million CHF | -9.19% |
| 2021 | 91.33 Million CHF | -3.21% |
| 2020 | 94.36 Million CHF | 7.41% |
| 2019 | 87.85 Million CHF | 2.37% |
| 2018 | 85.82 Million CHF | -0.3% |
| 2017 | 86.08 Million CHF | 96.68% |
| 2016 | 43.76 Million CHF | 1242.99% |
| 2015 | 3.25 Million CHF | -81.52% |
| 2014 | 17.63 Million CHF | -56.47% |
| 2013 | 40.5 Million CHF | 33.27% |
| 2012 | 30.39 Million CHF | -1.37% |
| 2011 | 30.81 Million CHF | -43.01% |
| 2010 | 54.07 Million CHF | -21.3% |
| 2009 | 68.7 Million CHF | -37.97% |
| 2008 | 110.75 Million CHF | -10.36% |
| 2007 | 123.55 Million CHF | 115.21% |
| 2006 | 57.41 Million CHF | -30.32% |
| 2005 | 82.39 Million CHF | -6.76% |
| 2004 | 88.36 Million CHF | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 77.3 Million CHF | 0.0% |
| 2023 Q1 | 78.25 Million CHF | -5.65% |
| 2023 Q2 | 78.25 Million CHF | 0.0% |
| 2023 Q4 | 75.9 Million CHF | 6.22% |
| 2023 FY | 75.9 Million CHF | -8.49% |
| 2023 Q3 | 71.46 Million CHF | -8.68% |
| 2022 Q3 | 82.94 Million CHF | -6.03% |
| 2022 Q2 | 88.26 Million CHF | 0.0% |
| 2022 Q1 | 88.26 Million CHF | -3.36% |
| 2022 FY | 82.94 Million CHF | -9.19% |
| 2022 Q4 | 82.94 Million CHF | 0.0% |
| 2021 Q2 | 93.49 Million CHF | 0.0% |
| 2021 FY | 91.33 Million CHF | -3.21% |
| 2021 Q4 | 91.33 Million CHF | 0.0% |
| 2021 Q1 | 93.49 Million CHF | -0.93% |
| 2021 Q3 | 91.33 Million CHF | -2.31% |
| 2020 Q3 | 94.36 Million CHF | 16.75% |
| 2020 Q4 | 94.36 Million CHF | 0.0% |
| 2020 FY | 94.36 Million CHF | 7.41% |
| 2020 Q2 | 80.82 Million CHF | 0.0% |
| 2020 Q1 | 80.82 Million CHF | -8.0% |
| 2019 Q1 | 81.12 Million CHF | -5.47% |
| 2019 Q3 | 87.85 Million CHF | 8.29% |
| 2019 Q2 | 81.12 Million CHF | 0.0% |
| 2019 FY | 87.85 Million CHF | 2.37% |
| 2019 Q4 | 87.85 Million CHF | 0.0% |
| 2018 Q2 | 78.96 Million CHF | 0.0% |
| 2018 Q3 | 85.82 Million CHF | 8.68% |
| 2018 Q1 | 78.96 Million CHF | -8.26% |
| 2018 FY | 85.82 Million CHF | -0.3% |
| 2018 Q4 | 85.82 Million CHF | 0.0% |
| 2017 Q3 | 86.08 Million CHF | -5.3% |
| 2017 FY | 86.08 Million CHF | 96.68% |
| 2017 Q1 | 90.89 Million CHF | 107.67% |
| 2017 Q4 | 86.08 Million CHF | 0.0% |
| 2017 Q2 | 90.89 Million CHF | 0.0% |
| 2016 Q3 | 43.76 Million CHF | -10.06% |
| 2016 FY | 43.76 Million CHF | 1242.99% |
| 2016 Q2 | 48.66 Million CHF | 0.0% |
| 2016 Q4 | 43.76 Million CHF | 0.0% |
| 2016 Q1 | 48.66 Million CHF | 1393.25% |
| 2015 Q3 | 16.18 Million CHF | 460.95% |
| 2015 FY | 3.25 Million CHF | -81.52% |
| 2015 Q2 | 2.88 Million CHF | 0.0% |
| 2015 Q4 | 3.25 Million CHF | -79.87% |
| 2014 Q4 | 17.63 Million CHF | 0.0% |
| 2014 FY | 17.63 Million CHF | -56.47% |
| 2014 Q2 | 19.39 Million CHF | 0.0% |
| 2013 Q2 | 19.68 Million CHF | -22.27% |
| 2013 Q3 | 16.77 Million CHF | -14.8% |
| 2013 Q1 | 25.32 Million CHF | -16.68% |
| 2013 FY | 40.5 Million CHF | 33.27% |
| 2013 Q4 | 40.5 Million CHF | 141.51% |
| 2012 Q4 | 30.39 Million CHF | -15.1% |
| 2012 Q1 | 9.29 Million CHF | -69.84% |
| 2012 Q2 | 37.85 Million CHF | 307.38% |
| 2012 Q3 | 35.79 Million CHF | -5.43% |
| 2012 FY | 30.39 Million CHF | -1.37% |
| 2011 Q2 | 43.13 Million CHF | -11.16% |
| 2011 Q3 | 38.77 Million CHF | -10.1% |
| 2011 Q4 | 30.81 Million CHF | -20.53% |
| 2011 FY | 30.81 Million CHF | -43.01% |
| 2011 Q1 | 48.54 Million CHF | -10.22% |
| 2010 Q1 | 56.48 Million CHF | -17.79% |
| 2010 FY | 54.07 Million CHF | -21.3% |
| 2010 Q4 | 54.07 Million CHF | -9.3% |
| 2010 Q3 | 59.61 Million CHF | -7.04% |
| 2010 Q2 | 64.13 Million CHF | 13.54% |
| 2009 Q4 | 68.7 Million CHF | 0.0% |
| 2009 FY | 68.7 Million CHF | -37.97% |
| 2008 FY | 110.75 Million CHF | -10.36% |
| 2007 FY | 123.55 Million CHF | 115.21% |
| 2006 FY | 57.41 Million CHF | -30.32% |
| 2005 FY | 82.39 Million CHF | -6.76% |
| 2004 FY | 88.36 Million CHF | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|